Psychedelic Spotlight News

  • Interview With Steven Huang, DEI Consultant at MAPS and Numinus

    Listen, Podcasts

    Steven’s consultancy company, Millennial HR Design, focuses on the intersection of DEI and psychedelics, where he intends to be a leverage point for the psychedelics industry to better understand their impact on marginalized communities. With nearly 10 years of industry experience, Steven hopes for more diverse and equitable representation in the psychedelic space. 

  • The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)

    Listen, Videos

    What’s up psychedelic investors! In this episode, we’ll be comparing the top 10 psychedelic stocks’ financials.
    Will look at the 4 most important financial stats for each of the top 10 companies in the Psychedelic Medicines field, selected by market cap.

    First, we will look at the market cap, because that tells us how valuable the market judges the company to be, and it tells us how easily a company can raise capital.
    Next, we will look at cash on hand.
    Third, we will look at how much a company is spending.
    Finally, we will look at revenue where applicable
    All figures are in American dollars.

    So which stocks we’ll be comparing, you may ask? We’ll look at:
    – Atai Life Sciences ( NASDAQ: ATAI)
    – Compass Pathways (NASDAQ: CMPS)
    -MindMed (NASDAQ: MNMD), ( NEO: MMED)
    – Cybin Inc (NYSE: CYBN)
    – Numinus Wellneass (TSX: NUMI) (OTC: LKYSF)
    – Revive Therapeutics (CN: RVV) (OTC: RVVTF)
    – Small Pharma ( TSX: DMT)
    -Mydecine (OTC: MYCOF) (NEO: MYCO)
    – Red Light Holland ( CSE: TRIP) (OTC: TRUFF)

    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #ATAISTOCK #PsychedelicStocks